Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 24833340)

1.

In vitro high throughput screening, what next? Lessons from the screening for aurora kinase inhibitors.

Hoang TM, Vu HL, Le LT, Nguyen CH, Molla A.

Biology (Basel). 2014 Feb 27;3(1):167-75. doi: 10.3390/biology3010167.

2.

High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.

Walker RG, Thomson G, Malone K, Nowicki MW, Brown E, Blake DG, Turner NJ, Walkinshaw MD, Grant KM, Mottram JC.

PLoS Negl Trop Dis. 2011 Apr 5;5(4):e1033. doi: 10.1371/journal.pntd.0001033.

3.

Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity.

Sarvagalla S, Singh VK, Ke YY, Shiao HY, Lin WH, Hsieh HP, Hsu JT, Coumar MS.

J Comput Aided Mol Des. 2015 Jan;29(1):89-100. doi: 10.1007/s10822-014-9807-2. Epub 2014 Oct 26.

PMID:
25344840
4.

High-Throughput and High-Content Screening for Huntington’s Disease Therapeutics.

Varma H, Lo DC, Stockwell BR.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press; 2011. Chapter 5.

5.
6.

Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.

Shun TY, Lazo JS, Sharlow ER, Johnston PA.

J Biomol Screen. 2011 Jan;16(1):1-14. doi: 10.1177/1087057110389039. Epub 2010 Dec 15.

PMID:
21160066
7.

High-throughput screening for protein tyrosine phosphatase activity modulators.

Tautz L, Sergienko EA.

Methods Mol Biol. 2013;1053:223-40. doi: 10.1007/978-1-62703-562-0_14.

PMID:
23860657
8.

Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach.

Duffy MR, Parker AL, Kalkman ER, White K, Kovalskyy D, Kelly SM, Baker AH.

J Control Release. 2013 Aug 28;170(1):132-40. doi: 10.1016/j.jconrel.2013.05.007. Epub 2013 May 20.

9.

Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).

Schröter T, Minond D, Weiser A, Dao C, Habel J, Spicer T, Chase P, Baillargeon P, Scampavia L, Schürer S, Chung C, Mader C, Southern M, Tsinoremas N, LoGrasso P, Hodder P.

J Biomol Screen. 2008 Jan;13(1):17-28. doi: 10.1177/1087057107310806.

PMID:
18227223
10.

Compound set enrichment: a novel approach to analysis of primary HTS data.

Varin T, Gubler H, Parker CN, Zhang JH, Raman P, Ertl P, Schuffenhauer A.

J Chem Inf Model. 2010 Dec 27;50(12):2067-78. doi: 10.1021/ci100203e. Epub 2010 Nov 12.

PMID:
21073183
11.

HTS promiscuity analyses for accelerating decision making.

Böcker A, Bonneau PR, Edwards PJ.

J Biomol Screen. 2011 Aug;16(7):765-74. doi: 10.1177/1087057111407763. Epub 2011 Jun 16.

PMID:
21680863
12.

High-throughput screening and biosensing with fluorescent C. elegans strains.

Leung CK, Deonarine A, Strange K, Choe KP.

J Vis Exp. 2011 May 19;(51). pii: 2745. doi: 10.3791/2745.

13.

Technological advances in high-throughput screening.

Liu B, Li S, Hu J.

Am J Pharmacogenomics. 2004;4(4):263-76. Review.

PMID:
15287820
14.
15.

Rethinking molecular similarity: comparing compounds on the basis of biological activity.

Petrone PM, Simms B, Nigsch F, Lounkine E, Kutchukian P, Cornett A, Deng Z, Davies JW, Jenkins JL, Glick M.

ACS Chem Biol. 2012 Aug 17;7(8):1399-409. doi: 10.1021/cb3001028. Epub 2012 May 31.

PMID:
22594495
16.

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Zhang JH, Chung TD, Oldenburg KR.

J Biomol Screen. 1999;4(2):67-73.

PMID:
10838414
17.

Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.

Gong LL, Fang LH, Peng JH, Liu AL, Du GH.

J Biotechnol. 2010 Feb 1;145(3):295-303. doi: 10.1016/j.jbiotec.2009.12.003. Epub 2009 Dec 4.

PMID:
19963024
18.

Mass spectrometric techniques for label-free high-throughput screening in drug discovery.

Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho PI, Zhang JH, Vickers C, Kaushik V, Hubbard B, Wang YK.

Anal Chem. 2007 Nov 1;79(21):8207-13. Epub 2007 Sep 29.

PMID:
17902631
19.

Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases.

Medina-Franco JL, Yoo J.

Mol Divers. 2013 May;17(2):337-44. doi: 10.1007/s11030-013-9428-z. Epub 2013 Feb 28.

PMID:
23447100
20.

High impact technologies for natural products screening.

Koehn FE.

Prog Drug Res. 2008;65:175, 177-210. Review.

PMID:
18084916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk